Adalimumab in severe and acute sciatica: A multicenter, randomized, double‐blind, placebo‐controlled trial

The addition of a short course of adalimumab to the treatment regimen of patients experiencing acute and severe sciatica resulted in a small decrease in leg pain and in significantly fewer surgical procedures.